Cochlear (Australia)

Cochlear (Australia)

Cochlear is a medical device company that designs, manufactures, and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant.Based in Sydney, Cochlear was formed in 1981 with finance from the Australian government to commercialise the implants pioneered by Dr. Graeme Clark. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Cochlear (Australia), Australia, covering academic research published from 2000 to 2021. Read More.


Open Access Percentage

36%


Total
Publications

994


Total Open
Publications

361


Total
Citations

20K


Open Access
Percentage

36%


Total
Publications

994


Total Open
Publications

361


Total
Citations

20K

Wikipedia

Website

download

Breakdown

9% 15% 12% 64%

Publisher Open

9%

Both

15%

Other Platform Open

12%

Closed

64%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

01020304050607080Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021

Open

Closed

Publisher Open

42%OA Journal

OA Journal 42%

103

Hybrid 37%

90

No Guarantees 21%

51

Other Platform Open

Domain 75%

204

Institution 39%

107

Public 13%

35

Other Internet 4%

11

Preprint 3%

7

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
204
Europe PMC
Domain
152
Semantic Scholar
Public
30
KU Leuven - Lirias
Institution
14
University of Melbourne - Minerva Access
Institution
10
uniroma1.it OAI-PMH Repository
Institution
10
University College London - UCL Discovery
Institution
9
University of Zurich - Zurich Open Repository and Archive
Institution
8
unimelb.edu.au OAI-PMH Repository
Institution
8
Red Federada de Repositorios Institucionales de Publicaciones Científicas - LA Referencia
Other Internet
8
1 / 7

Data updated 27 September 2022

Share

Share

Share